Startseite

Aktien

Integra Lifesciences Holdings

Nachrichten

Integra Lifesciences Holdings Aktie

Aktie

ISIN: US4579852082 WKN: 897013 SYM: IL3 Land Flagge US

USA

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

10,700

EUR

-1,83 %

-0,200 EUR

Letzter Kurs 16.01.26 Tradegate

Integra Lifesciences Holdings Aktie kaufen

Geldkurs

16.01.26

10,600

EUR

320 STK

Briefkurs

16.01.26

10,800

EUR

310 STK

Verkauf

Kauf

Hinweis
Verlängerte Handelszeiten
Ab sofort von 07:30 bis 23:00 Uhr

Neueste Nachrichten

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference 05.01.26 · globenewswire · Integra Lifesciences Holdings
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference 01.12.25 · globenewswire · Integra Lifesciences Holdings
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access 25.11.25 · globenewswire · Integra Lifesciences Holdings
Aesthetic Fillers Market Surges to USD 8.45 Billion by 2033, Propelled by 7.2% CAGR - Verified Market Reports 24.11.25 · PR Newswire (engl.) · Integra Lifesciences Holdings
Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries 11.11.25 · globenewswire · Integra Lifesciences Holdings
Integra LifeSciences Reports Third Quarter 2025 Financial Results 30.10.25 · globenewswire · Integra Lifesciences Holdings
Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025 15.10.25 · globenewswire · Integra Lifesciences Holdings
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting 08.10.25 · globenewswire · Integra Lifesciences Holdings
Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer 22.09.25 · globenewswire · Integra Lifesciences Holdings
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor Conferences 29.08.25 · globenewswire · Integra Lifesciences Holdings
Integra LifeSciences Reports Second Quarter 2025 Financial Results 31.07.25 · globenewswire · Integra Lifesciences Holdings
Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025 14.07.25 · globenewswire · Integra Lifesciences Holdings

1
2

Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference 112 Leser

IART Investors Have Opportunity to Join Integra LifeSciences Holdings Corporation Fraud ... 160 Leser
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 ... 156 Leser
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 156 Leser
Integra LifeSciences Leadership to Present at Wells Fargo and Morgan Stanley Healthcare Investor ... 152 Leser
Integra LifeSciences Reports First Quarter 2025 Financial Results 148 Leser
Integra LifeSciences Announces First Patient Enrolled in Acclarent AERA Pediatric Registry 140 Leser
Aesthetic Fillers Market Surges to USD 8.45 Billion by 2033, Propelled by 7.2% CAGR - Verified ... 132 Leser
INTEGRA STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Integra LifeSciences ... 128 Leser
Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, ... 128 Leser
Integra LifeSciences Reports Third Quarter 2025 Financial Results 128 Leser